Wed, March 20, 2024

Anupam Rama Maintained (SNDX) at Buy with Increased Target to $34 on, Mar 20th, 2024

Anupam Rama of JP Morgan, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Buy with Increased Target from $31 to $34 on, Mar 20th, 2024.

Anupam has made no other calls on SNDX in the last 4 months.



There are 3 other peers that have a rating on SNDX. Out of the 3 peers that are also analyzing SNDX, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • George Farmer of "Scotiabank" Downgraded from Buy to Hold and Decreased Target to $23 on, Wednesday, January 31st, 2024


These are the ratings of the 2 analyists that currently disagree with Anupam


  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $41 on, Wednesday, February 28th, 2024
  • Mara Goldstein of "Mizuho" Initiated at Strong Buy and Held Target at $45 on, Friday, December 22nd, 2023